Supplemental Figure 3 from Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non–Small Cell Lung Cancer
Authors:
- Mitchell S. von ItzsteinMIMitchell S. von Itzstein
- Timothy F. BurnsTBTimothy F. Burns
- Jonathan E. DowellJDJonathan E. Dowell
- Leora HornLHLeora Horn
- D. Ross CamidgeDCD. Ross Camidge
- Sally J. YorkSYSally J. York
- Keith D. EatonKEKeith D. Eaton
- Kelly KyleKKKelly Kyle
- Farjana FattahFFFarjana Fattah
- Jialiang LiuJLJialiang Liu
- Hong Mu-MosleyHMHong Mu-Mosley
- Arjun GuptaAGArjun Gupta
Open Access
- 17 February 2025
- other
- Published by American Association for Cancer Research (AACR)